Hims & Hers Health, Inc. (HIMS)
| Market Cap | 1.58B |
| Revenue (ttm) | 201.07M |
| Net Income (ttm) | -70.85M |
| Shares Out | 153.08M |
| EPS (ttm) | -0.59 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 30 |
| Last Price | $7.91 |
| Previous Close | $7.93 |
| Change ($) | -0.02 |
| Change (%) | -0.25% |
| Day's Open | 7.90 |
| Day's Range | 7.77 - 8.17 |
| Day's Volume | 2,448,461 |
| 52-Week Range | 7.77 - 25.40 |
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to ...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers releases survey findings on the pandemic's impact on Americans' mental health.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers releases survey findings on the pandemic's impact on Americans' mental health.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellnes...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands focus on sexual health with new product bundles.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has finalized the acquisition of teledermatology specialist, Apostrophe.
The potential for expansion coupled with a highly competitive pharmacy market has a BofA Securities analyst sidelined on shares of Hims & Hers Health, Inc. (NYSE:HIMS). The Hims Analyst: Michael Cherny ...
Urban Outfitters (URBN) partners with Hims & Hers Health to offer personalized wellness offerings to customers.
When Urban Outfitters announced a new partnership with direct-to-consumer health and wellness brand Hims & Hers, one way to look at it was simply an effort to get more diverse product offerings on the l...
After dabbling with group therapy during the pandemic, the telehealth company has decided to launch one-on-one teletherapy for $99 per session. Telehealth provider Hims & Hers is launching teletherapy s...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands mental health offerings to include one-on-one online therapy services.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has partnered with Urban Outfitters, starting with the availability of select Hims products on urbanoutfitters.com.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers acquires teledermatology specialist Apostrophe to deepen investment in dermatology.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers expands hair growth offerings with launch of Minoxidil 5% Foam, offering more choice and less stigma around hair loss.
The stock price for each of these companies dropped more than 5% on Tuesday.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has been named D-To-C Brand of The Year By Ad Age in the publication's A-List & Creativity Awards 2021.
Multispecialty telehealth platform Hims & Hers will acquire London-based health program Honest Health, which works in hair-loss-related products, a press release said Monday (June 14). With the acquisit...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers To Expand UK Footprint, Acquire London-Based Honest Health
A telehealth and health and wellness company that recently went public announced a new deal with platinum artist Miley Cyrus. What Happened: Miley Cyrus is joining as a creative advisor for Hims & Hers ...
Money has been flowing out of AMC Entertainment and into these up-and-coming short-squeeze candidates.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers has created an all-new treatment for hair loss that combines two of the most effective ingredients into a single spray.
Following their sector-wide correction, shares in these nine SPACs and former SPACs have fallen to an attractive entry point. The post 9 SPACs to Buy After the Selloff appeared first on InvestorPlace.
Looking for cheap telemedicine stocks on the move? Look no further.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will hold its vi...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced ...
Shares of Hims & Hers Health, Inc. (NYSE:HIMS) are in trouble. The stock is testing critical support and if this support holds, shares may rally.
Here are three companies with exciting growth stories that just went public.
These companies are at the forefront of innovation in the healthcare sector, and their stocks are surprisingly affordable too.
Ignore the near-term pullback in Hims & Hers. With its unique business model, telehealth play HIMS stock remains a potential long-term winner.
Hims & Hers CEO on portfolio expansion opportunities, company outlook
Yahoo Finance's Brian Sozzi, Myles Udland, and Julie Hyman speak with Hims & Hers Co-founder & CEO Andrew Dudum about the company's first earnings report since going public.
Shares of the newly public company dropped on weak guidance in its fourth-quarter earnings report.
There are a lot of crosscurrents in the market right now.
Multi-specialty telehealth platform Hims & Hers Health, Inc. reported that revenue surged 67 percent from the fourth quarter of 2019 to the fourth quarter of 2020. “This is an organization built on soli...
Hims & Hers Health Inc. (NYSE: HIMS) reported its financial results for the fiscal fourth quarter on Thursday that came in better than what analysts had anticipated, despite the ongoing Coronavirus pand...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported f...
SAN FRANCISCO--(BUSINESS WIRE)--Andrea Perez and Ambar Bhattacharyya join Hims & Hers Board of Directors to help the company pioneer a better way for patients to access healthcare.
A small company by the name of Conversion Labs (NASDAQ:CVLB) will be the eBay or Alibaba of the DTC telemedicine platforms space. The post This DTC Telemedicine Stock Has Enormous Potential Thanks to th...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will participate...
SPACs dominated Wall Street in 2020. The backwards IPOs of these three companies suggests that 2021 will be more of the same.
Telehealth is the future, and Hims & Hers looks well-positioned for that future. Growth should keep the rally in HIMS stock going.
The prospects for HIMS stock look good. The company has certainly built a robust platform.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, will release fis...
If you believe in the future of telemedicine, then keep an eye on HIMS stock. It might not be in the buy zone yet, though, so be patient.
The company has had early success in building a customer base as well as infrastructure to support their demand. HIMS offers frictionless patient to consumer experiences that are cost efficient and comp...
With its focus on millennials, fast growing telemedicine play HIMS stock has plenty of room to run after its recent SPAC merger. The post Buy Hims & Hers Stock for a Solid Play on Telehealth appeared fi...
Hims & Hers CEO on $1.6 billion SPAC deal and goal to provide affordable health care
Hims & Hers Co-Founder and CEO Andrew Dudum joins Yahoo Finance's Brain Sozzi and Julie Hyman to discuss the company's $1.6 billion SPAC deal with Oaktree Capital Management and discuss the future of me...
Hims & Hers, a San Francisco-based telehealth startup that sells sexual wellness and other health products and services to millennials, began trading publicly today on the NYSE after completing a revers...
Telehealth play HIMS stock makes its debut today. Here's what you should know about newly public Hims & Hers now.
About HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's cu... [Read more...]
| Industry Household & Personal Products | Founded 2017 |
| Stock Exchange NYSE | Ticker Symbol HIMS |
Financial Performance
In 2020, HIMS's revenue was $148.76 million, an increase of 80.18% compared to the previous year's $82.56 million. Losses were -$18.11 million, -74.86% less than in 2019.
Analyst Forecasts
The average 12-month stock price forecast for HIMS is 13.80, which is an increase of 74.46% from the latest price.